We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to April 2022 to March 2023
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 3 (1 October to 31 December 2023)
This report should be read in conjunction with the full KPI data tables…
Please be aware that this data covers the time period through the COVID-19…
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 2 (1 July to 30 September 2023)
This data report presents data about standards for screening activity related to the Sickle cell and thalassaemia screening (SCT) in England
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 2 (1 July 2022 - 30 September 2022)
Key performance indicator (KPI) data reports for NHS population screening programmes for financial year 2021 to 2022.
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 1 (1 April 2022 - 30 June 2022)
Data report for fetal anomaly screening, infectious diseases in pregnancy screening and sickle cell and thalassaemia screening 1 April 2020 to 31 March 2021.
Screening data for the NHS sickle cell and thalassaemia (SCT) screening programme for the year 1 April 2019 to 31 March 2020.
Data report for fetal anomaly screening, infectious diseases in pregnancy screening and sickle cell and thalassaemia screening 1 April 2019 to 31 March 2020.
Screening data for the NHS sickle cell and thalassaemia (SCT) screening programme for the year 1 April 2018 to 31 March 2019.
Key performance indicator (KPI) data reports for NHS population screening programmes for financial year 2019 to 2020.
Data report for fetal anomaly screening, infectious diseases in pregnancy screening and sickle cell and thalassaemia screening 1 April 2018 to 31 March 2019.
Data for the NHS sickle cell and thalassaemia screening programme for the year 1 April 2017 to 31 March 2018.
Joint data report for fetal anomaly screening, infectious diseases in pregnancy screening and sickle cell and thalassaemia screening 1 April 2017 to 31 March 2018.
Key performance indicator (KPI) data reports for NHS population screening programmes for financial year 2018 to 2019.
The report briefly defines genome sequencing and how, by improving our understanding of genetic activity, we can determine how best to use genetics in screening.
Key performance indicator (KPI) data reports for NHS population screening programmes for financial year 2017 to 2018.
These reports set out the annual data collected from the linked antenatal and newborn sickle cell and thalassaemia (SCT) screening programme.
Executive summary of quality assurance (QA) visit to the NHS antenatal and newborn screening programme run by the Dudley Group NHS Foundation Trust.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).